微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 7.13% | 65.43% | 59.51% | 40/158 | 1.25% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 4.47% | 136.51% | 153.98% | 37/158 | 0.28% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 1.76% | 61.47% | -58.49% | 63/158 | -0.34% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 4.24% | 153.88% | -1.62% | 65/158 | -9.6% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 4.31% | 167.24% | 128.04% | 69/158 | 4.24% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 1.89% | 129.72% | 73.39% | 85/158 | 2.68% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 1.09% | 146.58% | 113.85% | 92/158 | 2.33% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | -7.87% | 14.64% | -22.78% | 124/158 | -1% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | -6.41% | -499.07% | -0.79% | 127/158 | 2.35% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | -6.36% | -7166.67% | -171.79% | 128/158 | 1.47% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | -2.34% | -490% | 74.62% | 130/158 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | -9.22% | -185.77% | -761.68% | 122/158 | 0.72% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | -1.07% | -108.55% | -1288.89% | 115/158 | 2.84% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 0.09% | -98.91% | -85% | 115/158 | 2.19% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 0.6% | -89.51% | -94.42% | 103/158 | 1.58% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 10.75% | -55.63% | -14.14% | 38/158 | 0.79% | ST人福 | 6.82% | 行业排名> |
| 2021-09-30 | 12.52% | -30.75% | 51.03% | 17/158 | 4.44% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 8.29% | -4.05% | 44.93% | 23/158 | 2.97% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 5.72% | 37.83% | -76.39% | 6/158 | 2.47% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 24.23% | -30.77% | 34.02% | 12/158 | 3.66% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 18.08% | -35.77% | 109.26% | 7/158 | 3.07% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 8.64% | -52.61% | 108.19% | 28/158 | 4.23% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 4.15% | -57.22% | -88.14% | 20/158 | 2.2% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 35% | -13.98% | 24.33% | 1/158 | 2.57% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 28.15% | 1366.15% | 54.42% | 1/158 | 7.53% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 18.23% | 1157.24% | 87.94% | 2/158 | 5% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 9.7% | -19.7% | -76.16% | 1/158 | 2.43% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 40.69% | 1894.61% | 2019.27% | 1/158 | 7.17% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 1.92% | 40.15% | 32.41% | 90/158 | 7.21% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 1.45% | 222.22% | -88% | 91/158 | 4.64% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 12.08% | 1648.72% | 492.16% | 1/158 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 2.04% | 482.86% | 48.91% | 108/158 | 9.68% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 1.37% | 813.33% | 204.44% | 88/158 | 8.34% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 0.45% | 152.94% | 157.69% | 97/158 | 5.62% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | -0.78% | 25.71% | -322.86% | 82/158 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 0.35% | -91.84% | 133.33% | 103/158 | 6.22% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 0.15% | -96.72% | 117.65% | 78/158 | 5.64% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | -0.85% | -115.48% | 19.05% | 84/158 | 3.52% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | -1.05% | -127.56% | -124.48% | 77/158 | 2.69% | 贝达药业 | 16.78% | 行业排名> |